4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-15-002579
CIK 0000887247operating
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:29 PM ET
Size
7.4 KB
Accession
0001387131-15-002579
Insider Transaction Report
Form 4
ROTHERMEL ROBERT B
Director
Transactions
- Purchase
Common Stock
2015-08-13$3.30/sh+5,000$16,494→ 25,000 total - Purchase
Common Stock
2015-08-14$3.40/sh+2,000$6,800→ 27,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted avergae price. These shares were purchased in multiple transactions at prices ranging from $3.24 to $3.30, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.358 to $3.426, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:29 PM ET
- Size
- 7.4 KB